What are the implications of the LEADER trial for practitioners at the front lines of diabetes care? And how will it fit into the treatment algorithm?

What are the implications of the LEADER trial for practitioners at the front lines of diabetes care? And how will it fit into the treatment algorithm?

What are the implications of the LEADER trial for practitioners at the front lines of diabetes care? And how will it fit into the treatment algorithm?


Created by

CMEducation Resources IQ&A Interactive Intelligence Zone

Presenter

Robert Henry, MD

Robert Henry, MD

Chief, Center for Metabolic Research
Chief, Section of Endocrinology, Metabolism & Diabetes
Veterans Affairs Healthcare System
Professor of Medicine‚ Department of Medicine
Division of Endocrinology and Metabolism
University of California‚ San Diego